Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2.
Vleugels RA, Piraccini BM, Mesinkovska N, Mostaghimi A, Shimomura Y, Sontag A, McSwiney F, Somani N, Pandey H, Denning K, King B
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.